×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
mRNA levels of 10 BCAR genes (AKT1, AKT2, BCAR1, BCAR3, EGFR, ERBB2 , GRB7, SRC, TLE3, and TRERF1) were measured in estrogen receptor-positive breast tumors using quantitative reverse-transcriptase polymerase chain reaction.
19075277 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
12006526 2002
×
Entrez Id: 11200
Gene Symbol: CHEK2
CHEK2
Mammary Neoplasms
0.500
Biomarker
CTD_human
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.
12690581 2003
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
HER2 overexpression as a predictive marker in a randomized trial comparing adjuvant cyclophosphamide/methotrexate/5-fluorouracil with epirubicin in patients with stage I/II breast cancer: long-term results.
16137437 2005
×
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Adjuvant systemic therapy for breast cancer in BRCA1BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
20135344 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.
16865596 2006
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
19896266 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group.
16234514 2005
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
19801490 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
19436038 2009
×
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
Mammary Neoplasms
0.500
Biomarker
CTD_human
PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality.
19685490 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
17614302 2007
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat.
18840765 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
11248153 2001
×
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
Mammary Neoplasms
0.500
Biomarker
CTD_human
Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
10788334 2000
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
[Efficacy and toxicity of trastuzumab combined vinorelbine in 21 patients with HER2 overexpressing metastatic breast cancer].
18819904 2008
×
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
Mammary Neoplasms
0.500
Biomarker
CTD_human
We found that activation of the latent Pik3ca (H1047R) allele resulted in breast tumors with multiple histological types.
22370636 2013
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
16596621 2006
×
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
Mammary Neoplasms
0.500
Biomarker
CTD_human
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.
7894491 1994
×
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
Mammary Neoplasms
0.500
Biomarker
CTD_human
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.
28825726 2017
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
16495393 2006
×
Entrez Id: 2099
Gene Symbol: ESR1
ESR1
Mammary Neoplasms
0.500
Biomarker
CTD_human
Discovery at the interface: Toward novel anti-proliferative agents targeting human estrogen receptor/S100 interactions.
27580430 2016
×
Entrez Id: 2065
Gene Symbol: ERBB3
ERBB3
Mammary Neoplasms
0.500
Biomarker
CTD_human
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.
21638049 2012
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients.
15970926 2005
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Neoplasms
0.500
Biomarker
CTD_human
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.
15994142 2005